1980
DOI: 10.1139/o80-082
|View full text |Cite
|
Sign up to set email alerts
|

Purine synthesis de novo and its regulation in rat hepatocytes

Abstract: Purine synthesis de novo and its regulation were studied in freshly isolated hepatocytes from fed adult male rats. The cells incorporated [14C]formate mainly into purine ribonucleotides. The immediate effect of increasing the concentration of inorganic phosphate in the incubation medium was an increase in 5-phosphoribosyl 1-pyrophosphate (PP-ribose-P) availability and a stimulation of purine synthesis de novo. However, prolonged incubation of cells in 25 mM phosphate resulted in a decreased PP-ribose-P availab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
4
0

Year Published

1982
1982
1998
1998

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 14 publications
1
4
0
Order By: Relevance
“…Therefore, although there was no strict correlation between glucose output and urate formation, it seems to be possible that the elevated level of glucose-6-phosphate caused an enhanced flux into the pentose phosphate pathway replenishing the 5-phosphoribosyl-l-pyrophosphate pool and in turn increasing purine nucleotide synthesis. This hypothesis is in agreement with the finding that glucagon, cAMP or adrenaline (noradrenaline was not tested) increased the levels of 5-phosphoribosyl-l-pyrophosphate in rat hepatocytes by 1.5-2-fold although with considerably slower kinetics [25,26]. The finding that adrenaline (noradrenaline was not studied) increased urate formation slightly by 1.2-1.5-fold in chicken hepatocytes again with considerably slower kinetics [27] cannot be compared with the present observations since in birds urate is the end product not only of the degradation of purine nucleotides as in mammals but of all nitrogenous compounds including amino acids.…”
Section: Discussionsupporting
confidence: 91%
“…Therefore, although there was no strict correlation between glucose output and urate formation, it seems to be possible that the elevated level of glucose-6-phosphate caused an enhanced flux into the pentose phosphate pathway replenishing the 5-phosphoribosyl-l-pyrophosphate pool and in turn increasing purine nucleotide synthesis. This hypothesis is in agreement with the finding that glucagon, cAMP or adrenaline (noradrenaline was not tested) increased the levels of 5-phosphoribosyl-l-pyrophosphate in rat hepatocytes by 1.5-2-fold although with considerably slower kinetics [25,26]. The finding that adrenaline (noradrenaline was not studied) increased urate formation slightly by 1.2-1.5-fold in chicken hepatocytes again with considerably slower kinetics [27] cannot be compared with the present observations since in birds urate is the end product not only of the degradation of purine nucleotides as in mammals but of all nitrogenous compounds including amino acids.…”
Section: Discussionsupporting
confidence: 91%
“…Such a result was surprising, since these agents have been shown to stimulate this pathway in many different cell types [25][26][27][28]. However, it is possible to activate the PPP without increasing PRPP levels [68,69]. It is also possible that an increase in PRPP in response to these agents was transient and not detected because of the time point chosen, or that, under the conditions of this experiment, metabolic pathways utilizing PRPP consumed this substrate before it could accumulate within the complexes.…”
Section: Discussionmentioning
confidence: 99%
“…To examine the effect of the continuous supply of Hx on the increased rate of the de novo pathway by glucagon in liver (19), 0.5 mg of glucagon/200 g of body weight/12 h with or without Hx of 5.0 mol/200 g of body weight/12 h was similarly infused, and the metabolic rate of the de novo pathway in liver was determined. The stimulative effect of glucagon on the de novo purine synthesis in liver has been reported (19,20) and is applied to glucagon and insulin therapy for acute liver failure.…”
Section: Methodsmentioning
confidence: 99%